Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 939

1.

A Multicenter Japanese Survey Assessing the Long-Term Outcomes of Liver Retransplantation using Living Donor Grafts.

Kuramitsu K, Fukumoto T, Egawa H, Ohdan H, Umeshita K, Uemoto S, Hibi T, Kasahara M, Yoshizumi T, Mizuta K, Shimamura T, Furukawa H.

Transplantation. 2019 Sep 13. doi: 10.1097/TP.0000000000002958. [Epub ahead of print]

PMID:
31568214
2.

Long-term impact and clinical significance of living donor liver transplantation with respect to donor liver restoration and spleen size: a prospective study.

Yoshino K, Taura K, Ikeno Y, Kimura Y, Hai Nam N, Uemoto Y, Okuda Y, Nishio T, Yamamoto G, Iwaisako K, Seo S, Kaido T, Uemoto S.

Am J Transplant. 2019 Sep 30. doi: 10.1111/ajt.15627. [Epub ahead of print]

PMID:
31566887
3.

Anatomical pitfall in right posterior sector graft procurement in living donor liver transplantation.

Kusakabe J, Yagi S, Okamura Y, Iida T, Ogawa E, Ito T, Hata K, Taura K, Okajima H, Kaido T, Uemoto S.

Liver Transpl. 2019 Sep 28. doi: 10.1002/lt.25648. [Epub ahead of print]

PMID:
31563152
4.

A Dual Protective Effect of Intestinal Remote Ischemic Conditioning in a Rat Model of Total Hepatic Ischemia.

Czigany Z, Hata K, Lai W, Schwandt T, Yamamoto Y, Uemoto S, Tolba RH.

J Clin Med. 2019 Sep 26;8(10). pii: E1546. doi: 10.3390/jcm8101546.

5.

A clinical pilot study of Resection Process Map: A novel virtual hepatectomy software to visualize the resection process, case series.

Uchida Y, Taura K, Nakao M, Uemoto S.

Int J Surg. 2019 Sep 13;71:36-40. doi: 10.1016/j.ijsu.2019.09.002. [Epub ahead of print]

PMID:
31525504
6.

Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 cases.

Chaudhary RJ, Higuchi R, Nagino M, Unno M, Ohtsuka M, Endo I, Hirano S, Uesaka K, Hasegawa K, Wakai T, Uemoto S, Yamamoto M.

J Hepatobiliary Pancreat Sci. 2019 Sep 13. doi: 10.1002/jhbp.668. [Epub ahead of print]

PMID:
31520452
7.

Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Uemoto S.

Clin Nutr. 2019 Aug 21. pii: S0261-5614(19)33024-9. doi: 10.1016/j.clnu.2019.08.012. [Epub ahead of print]

PMID:
31481263
8.

Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study.

Yoh T, Cauchy F, Le Roy B, Seo S, Taura K, Hobeika C, Dokmak S, Farges O, Gelli M, Sa Cunha A, Adam R, Uemoto S, Soubrane O.

Surgery. 2019 Aug 14. pii: S0039-6060(19)30413-1. doi: 10.1016/j.surg.2019.06.025. [Epub ahead of print]

PMID:
31421869
9.

Combination of postoperative C-reactive protein value and computed tomography imaging can predict severe pancreatic fistula after pancreatoduodenectomy.

Uchida Y, Masui T, Nakano K, Yogo A, Yoh T, Nagai K, Anazawa T, Takaori K, Uemoto S.

HPB (Oxford). 2019 Aug 12. pii: S1365-182X(19)30611-2. doi: 10.1016/j.hpb.2019.06.020. [Epub ahead of print]

PMID:
31416787
10.

Right hepatectomy with en-bloc resection of bilateral hepatic arteries for Bismuth type IIIa hilar cholangiocarcinoma: A case report.

Ataka R, Yagi S, Taura K, Uemoto S.

Asian J Surg. 2019 Aug 9. pii: S1015-9584(19)30621-9. doi: 10.1016/j.asjsur.2019.07.018. [Epub ahead of print] No abstract available.

11.

Auxiliary xenotransplantation as an in vivo bioreactor-Development of a transplantable liver graft from a tiny partial liver.

Masano Y, Yagi S, Miyachi Y, Okumura S, Kaido T, Haga H, Kobayashi E, Uemoto S.

Xenotransplantation. 2019 Aug 9:e12545. doi: 10.1111/xen.12545. [Epub ahead of print]

PMID:
31400029
12.

Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: An observational cohort study.

Nakamura T, Fujikura J, Anazawa T, Ito R, Ogura M, Okajima H, Uemoto S, Inagaki N.

J Diabetes Investig. 2019 Aug 7. doi: 10.1111/jdi.13128. [Epub ahead of print]

13.

Different clinical risk scores for prediction of early mortality after liver resection for hepatocellular carcinoma: which is the best?

Badawy A, Seo S, Toda R, Fuji H, Fukumitsu K, Taura K, Kaido T, Uemoto S.

ANZ J Surg. 2019 Oct;89(10):1275-1280. doi: 10.1111/ans.15368. Epub 2019 Aug 6.

PMID:
31389123
14.

Antibiotic pretreatment alleviates liver transplant damage in mice and humans.

Nakamura K, Kageyama S, Ito T, Hirao H, Kadono K, Aziz A, Dery KJ, Everly MJ, Taura K, Uemoto S, Farmer DG, Kaldas FM, Busuttil RW, Kupiec-Weglinski JW.

J Clin Invest. 2019 Jul 22;129(8):3420-3434. doi: 10.1172/JCI127550. eCollection 2019 Jul 22.

15.

Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation.

Iwaki K, Yagi S, Morita S, Hamaguchi Y, Masano Y, Yamamoto G, Ogawa E, Nagai K, Kamo N, Hata K, Taura K, Okajima H, Kaido T, Uemoto S.

Transplant Proc. 2019 Jul - Aug;51(6):1779-1784. doi: 10.1016/j.transproceed.2019.03.038. Epub 2019 Jul 10.

PMID:
31301855
16.

Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small-for-Size Grafts.

Macshut M, Kaido T, Yao S, Yagi S, Ito T, Kamo N, Nagai K, Sharshar M, Uemoto S.

Liver Transpl. 2019 Oct;25(10):1524-1532. doi: 10.1002/lt.25601. Epub 2019 Aug 14.

PMID:
31298473
17.

Senescence caused by inactivation of the homeodomain transcription factor Pdx1 in adult pancreatic acinar cells in mice.

Horiguchi M, Yoshida M, Hirata K, Furuyama K, Masui T, Uemoto S, Kawaguchi Y.

FEBS Lett. 2019 Aug;593(16):2226-2234. doi: 10.1002/1873-3468.13504. Epub 2019 Jun 30.

PMID:
31240701
18.

Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.

Nakamura N, Hatano E, Iguchi K, Sato M, Kawaguchi H, Ohtsu I, Sakurai T, Aizawa N, Iijima H, Nishiguchi S, Tomono T, Okuda Y, Wada S, Seo S, Taura K, Uemoto S, Ikegawa M.

BMC Cancer. 2019 Jun 25;19(1):621. doi: 10.1186/s12885-019-5825-8.

19.

Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury.

Miyauchi T, Uchida Y, Kadono K, Hirao H, Kawasoe J, Watanabe T, Ueda S, Okajima H, Terajima H, Uemoto S.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13533-13542. doi: 10.1073/pnas.1820282116. Epub 2019 Jun 13.

20.

Outcomes of liver transplantation for Alagille syndrome after Kasai portoenterostomy: Alagille Syndrome with agenesis of extrahepatic bile ducts at porta hepatis.

Gunadi, Kaneshiro M, Okamoto T, Sonoda M, Ogawa E, Okajima H, Uemoto S.

J Pediatr Surg. 2019 May 6. pii: S0022-3468(19)30323-9. doi: 10.1016/j.jpedsurg.2019.04.022. [Epub ahead of print]

PMID:
31104835
21.

A Minimal Physiologically-Based Pharmacokinetic Model for Tacrolimus in Living-Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype.

Itohara K, Yano I, Tsuzuki T, Uesugi M, Nakagawa S, Yonezawa A, Okajima H, Kaido T, Uemoto S, Matsubara K.

CPT Pharmacometrics Syst Pharmacol. 2019 Aug;8(8):587-595. doi: 10.1002/psp4.12420. Epub 2019 Jun 9.

22.

Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society.

Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, Uemoto S, Ohdan H.

Hepatol Res. 2019 Sep;49(9):964-980. doi: 10.1111/hepr.13364. Epub 2019 Jul 18.

PMID:
31081572
23.

Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.

Yoh T, Seo S, Taura K, Iguchi K, Ogiso S, Fukumitsu K, Ishii T, Kaido T, Uemoto S.

Ann Surg. 2019 Apr 30. doi: 10.1097/SLA.0000000000003358. [Epub ahead of print]

PMID:
31058698
24.

Bolus Administration of Polyamines Boosts Effects on Hepatic Ischemia-Reperfusion Injury and Regeneration in Rats.

Doi J, Fujimoto Y, Teratani T, Kasahara N, Maeda M, Tsuruyama T, Iida T, Yagi S, Uemoto S.

Eur Surg Res. 2019;60(1-2):63-73. doi: 10.1159/000497434. Epub 2019 May 3.

PMID:
31055575
25.

The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia⁻Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats.

Iwasaki J, Afify M, Bleilevens C, Klinge U, Weiskirchen R, Steitz J, Vogt M, Yagi S, Nagai K, Uemoto S, Tolba RH.

Int J Mol Sci. 2019 Apr 29;20(9). pii: E2114. doi: 10.3390/ijms20092114.

26.

Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold.

Minami T, Ishii T, Yasuchika K, Fukumitsu K, Ogiso S, Miyauchi Y, Kojima H, Kawai T, Yamaoka R, Oshima Y, Kawamoto H, Kotaka M, Yasuda K, Osafune K, Uemoto S.

Regen Ther. 2019 Mar 30;10:127-133. doi: 10.1016/j.reth.2019.03.002. eCollection 2019 Jun.

27.

Laparoscopic approach for choledochojejunostomy.

Hori T, Aisu Y, Yamamoto M, Yasukawa D, Iida T, Yagi S, Taniguchi K, Uemoto S.

Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):285-288. doi: 10.1016/j.hbpd.2019.04.004. Epub 2019 Apr 17. No abstract available.

PMID:
31023579
28.

Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, Okajima H, Uemoto S.

Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. Epub 2018 Jun 5.

29.

The Efficacy and Limitations of Postoperative Adjuvant Chemotherapy in Patients With Extrahepatic Cholangiocarcinoma.

Morino K, Seo S, Yoh T, Nishino H, Yamanaka K, Fukumitsu K, Ishii T, Taura K, Okajima H, Kaido T, Uemoto S.

Anticancer Res. 2019 Apr;39(4):2155-2161. doi: 10.21873/anticanres.13329.

PMID:
30952762
30.

Laparoscopic Left Lateral Sectionectomy Using the Extrahepatic Glissonean Approach: A Secure Option for Achieving a Negative Margin for Lesions with Ductal Extension.

Ogiso S, Seo S, Okumura S, Ishii T, Fukumitsu K, Ito T, Masui T, Taura K, Kaido T, Uemoto S.

Ann Surg Oncol. 2019 Jun;26(6):1858. doi: 10.1245/s10434-019-07298-8. Epub 2019 Mar 18.

PMID:
30887372
31.

Significance of preoperative sarcopenia to liver surgery.

Kaido T, Hamaguchi Y, Uemoto S.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):59-62. doi: 10.21037/hbsn.2018.11.05. No abstract available.

32.

Predictive value of the Ki67 index for lymph node metastasis of small non-functioning pancreatic neuroendocrine neoplasms.

Masui T, Sato A, Nakano K, Uchida Y, Yogo A, Anazawa T, Nagai K, Kawaguchi Y, Takaori K, Uemoto S.

Surg Today. 2019 Jul;49(7):593-600. doi: 10.1007/s00595-019-01779-9. Epub 2019 Mar 5.

PMID:
30838442
33.

Impact of imbalanced graft-to-spleen volume ratio on outcomes following living donor liver transplantation in an era when simultaneous splenectomy is not typically indicated.

Yao S, Kaido T, Yagi S, Uozumi R, Iwamura S, Miyachi Y, Shirai H, Kamo N, Taura K, Okajima H, Uemoto S.

Am J Transplant. 2019 Oct;19(10):2783-2794. doi: 10.1111/ajt.15337. Epub 2019 Mar 26.

PMID:
30830721
34.

Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months.

Nishino H, Hatano E, Okuno M, Toda R, Seo S, Taura K, Horimatsu T, Kanai M, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S.

Am Surg. 2019 Feb 1;85(2):e111-e114. No abstract available.

PMID:
30819321
35.

Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience.

Ueda Y, Kobayashi T, Ikegami T, Miuma S, Mizuno S, Akamatsu N, Takaki A, Ishigami M, Takatsuki M, Sugawara Y, Maehara Y, Uemoto S, Seno H.

J Gastroenterol. 2019 Jul;54(7):660-666. doi: 10.1007/s00535-019-01561-1. Epub 2019 Feb 26.

PMID:
30806783
36.

Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.

Kim SK, Takeda H, Takai A, Matsumoto T, Kakiuchi N, Yokoyama A, Yoshida K, Kaido T, Uemoto S, Minamiguchi S, Haga H, Shiraishi Y, Miyano S, Seno H, Ogawa S, Marusawa H.

J Gastroenterol. 2019 Jul;54(7):628-640. doi: 10.1007/s00535-019-01555-z. Epub 2019 Feb 12.

PMID:
30756187
37.

Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.

Kaido T, Kamo N, Uemoto S.

Clin Nutr. 2019 Apr;38(2):967. doi: 10.1016/j.clnu.2019.01.024. Epub 2019 Feb 1. No abstract available.

PMID:
30739810
38.

Exocrine tissue-driven TFF2 prevents apoptotic cell death of endocrine lineage during pancreas organogenesis.

Hirata K, Kodama S, Nakano Y, Minaki-Nakagawa Y, Aoyama Y, Sakikubo M, Goto T, Yoshida M, Masui T, Yamamoto T, Uemoto S, Kawaguchi Y.

Sci Rep. 2019 Feb 7;9(1):1636. doi: 10.1038/s41598-018-38062-9.

39.

Clinical and experimental studies of intraperitoneal lipolysis and the development of clinically relevant pancreatic fistula after pancreatic surgery.

Uchida Y, Masui T, Nakano K, Yogo A, Sato A, Nagai K, Anazawa T, Takaori K, Tabata Y, Uemoto S.

Br J Surg. 2019 Apr;106(5):616-625. doi: 10.1002/bjs.11075. Epub 2019 Feb 6.

PMID:
30725479
40.

Early post-operative intravenous tacrolimus in pediatric liver transplant recipients is not superior to oral tacrolimus.

Sabra TA, Okajima H, Yoshizawa A, Ogawa E, Okamoto S, Osman MA, Saad-Eldin Y, Uemoto S.

Pediatr Transplant. 2019 May;23(3):e13368. doi: 10.1111/petr.13368. Epub 2019 Feb 4.

PMID:
30719833
41.

Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience.

Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S.

Hepatol Res. 2019 Jun;49(6):687-694. doi: 10.1111/hepr.13320. Epub 2019 Mar 1.

PMID:
30698359
42.

Current state and future evolution of pancreatic islet transplantation.

Anazawa T, Okajima H, Masui T, Uemoto S.

Ann Gastroenterol Surg. 2018 Oct 8;3(1):34-42. doi: 10.1002/ags3.12214. eCollection 2019 Jan. Review.

43.

Reappraisal of Prognostic Impact of Tumor SUVmax by 18F-FDG-PET/CT in Intrahepatic Cholangiocarcinoma.

Yoh T, Seo S, Morino K, Fuji H, Ikeno Y, Ishii T, Taura K, Nakamoto Y, Higashi T, Kaido T, Uemoto S.

World J Surg. 2019 May;43(5):1323-1331. doi: 10.1007/s00268-019-04917-z.

PMID:
30680501
44.

Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study.

Ueda D, Yoshizawa A, Kaneshiro M, Hirata Y, Yagi S, Hata K, Okajima H, Egawa H, Uemoto S.

Transplant Direct. 2018 Dec 27;5(1):e420. doi: 10.1097/TXD.0000000000000858. eCollection 2019 Jan.

45.

POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.

Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

Sci Rep. 2019 Jan 14;9(1):102. doi: 10.1038/s41598-018-36490-1.

46.

Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies.

Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Uozumi R, Yagi S, Uemoto S.

Clin Nutr. 2018 Dec 17. pii: S0261-5614(18)32570-6. doi: 10.1016/j.clnu.2018.12.004. [Epub ahead of print]

PMID:
30595376
47.

The Relationship Between 18F-FDG Uptake on PET/CT and Markers of Systemic Inflammatory Response in Patients Undergoing Surgery for Intrahepatic Cholangiocarcinoma.

Seo S, Yoh T, Morino K, Fuji H, Taura K, Fukumitsu K, Ishii T, Nakamoto Y, Kaido T, Uemoto S.

Anticancer Res. 2019 Jan;39(1):341-346. doi: 10.21873/anticanres.13117.

PMID:
30591478
48.

Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infection.

Inuzuka T, Ueda Y, Arasawa S, Takeda H, Matsumoto T, Osaki Y, Uemoto S, Seno H, Marusawa H.

Sci Rep. 2018 Dec 24;8(1):18070. doi: 10.1038/s41598-018-36093-w.

49.

Correction: Hammad, A.; Kaido, T.; Aliyev V.; Mandato C.; Uemoto S. Nutritional Therapy in Liver Transplantation. Nutrients 2017; 9. E1126.

Hammad A, Kaido T, Aliyev V, Mandato C, Uemoto S.

Nutrients. 2018 Dec 18;10(12). pii: E2006. doi: 10.3390/nu10122006.

50.

Impact of pretreatments on outcomes after living donor liver transplantation for hepatocellular carcinoma.

Ogawa K, Kaido T, Okajima H, Fujimoto Y, Yoshizawa A, Yagi S, Hori T, Iida T, Takada Y, Uemoto S.

J Hepatobiliary Pancreat Sci. 2019 Feb;26(2):73-81. doi: 10.1002/jhbp.602. Epub 2019 Jan 21.

PMID:
30561147

Supplemental Content

Loading ...
Support Center